Breaking News Instant updates and real-time market news.

EGLT

Egalet

$1.15

-0.04 (-3.36%)

, CVS

CVS Health

$71.38

0.37 (0.52%)

08:48
12/07/17
12/07
08:48
12/07/17
08:48

CVS removes Egalet's Sprix Nasal Spray from 2018 formulary

Egalet (EGLT) disclosed last night that it has been notified verbally by CVS Caremark (CVS), a pharmacy benefits manager, that Sprix Nasal Spray will no longer be on its formulary for a portion of its commercial covered lives beginning January 1, 2018. Egalet estimates that approximately 20% of Sprix prescriptions could be impacted by Caremark's planned action. In response to this change in coverage, the company intends to continue to work with several other payers to ensure patient access to Sprix. Egalet "believes that its market access strategy will help to enable it to mitigate the impact of this change and help to enable further growth of Sprix, particularly given the Company's relatively nominal share of the market for nonsteroidal anti-inflammatory drugs, or NSAIDs." Egalet shares are down 12c to $1.03 in premarket trading.

EGLT

Egalet

$1.15

-0.04 (-3.36%)

CVS

CVS Health

$71.38

0.37 (0.52%)

  • 12

    Dec

EGLT Egalet
$1.15

-0.04 (-3.36%)

11/09/17
GABE
11/09/17
DOWNGRADE
GABE
Hold
Egalet downgraded to Hold from Buy at Gabelli
Gabelli analyst Kevin Kedra downgraded Egalet to Hold citing challenges for Arymo, potential generic competition for Sprix, and lack of near-term catalysts.
09/12/17
CANT
09/12/17
NO CHANGE
Target $7
CANT
Overweight
Investors should consider owning Egalet, says Cantor
Cantor Fitzgerald analyst Brandon Folkes saying the company's five posters at Pain Week last week reinforced the sales potential of, and need for, abuse deterent products such as Arymo ER. With three approved products and a cash runway through 2020, investors should consider owning Egalet shares, Folkes tells investors in a research note. He reiterates an Overweight rating on the shares with a $7 price target.
08/14/17
CANT
08/14/17
INITIATION
CANT
Overweight
Egalet coverage assumed with an Overweight at Cantor
Cantor analyst Brandon Folkes, assumed coverage of Egalet with a $7 price target and an Overweight rating. He says that the company is poised "to benefit from the need to reduce opioid abuse" while lowering patients' pain. The analyst says that a "strong launch" of the company's Arymo ER drug could spur many more investors to buy its shares.
06/09/17
JMPS
06/09/17
NO CHANGE
JMPS
Egalet may benefit from increased scrutiny of opioids, says JMP Securities
After the FDA requested that Endo (ENDP) remove its Opana ER opioid from the market due to increased risk of abuse using injections, JMP Securities analyst Jason Butler says that Egalet's (EGLT) abuse deterrent opioid alternatives could be boosted by the FDA's increased scrutiny of opioids. The analyst reiterates a $15 price target and Outperform rating on the stock.
CVS CVS Health
$71.38

0.37 (0.52%)

12/06/17
ARGS
12/06/17
DOWNGRADE
ARGS
Hold
Aetna downgraded to Hold from Buy at Argus
Argus analyst David Toung downgraded Aetna (AET) to Hold from Buy following the CVS Health (CVS) merger announcement, saying a more neutral view is now appropriate after a run-up in the stock price which outperformed over the past 5 years. Toung also notes the company is faced with potential risks around regulatory changes in the Medicare Advantage and Medicaid markets as well as possible margin pressure from higher post-merger utilization amid a moderate cost trend medical environment.
12/06/17
BERN
12/06/17
UPGRADE
Target $65
BERN
Market Perform
Express Scripts upgraded to Market Perform from Underperform at Bernstein
Bernstein upgraded Express Scripts to Market Perform from Underperform, with a $65 price target, based upon improved upside risks from potential policy and competitor actions and valuation. Give recent developments, the analyst sees certain upside opportunities to Express Scripts, specifically tax reform, a potential CVS Health (CVS)/Aetna (AET) merger, and a potential entry by Amazon (AMZN) into pharmacy.
12/05/17
BMOC
12/05/17
NO CHANGE
Target $200
BMOC
Market Perform
Aetna-CVS deal is a high risk-reward strategy, says BMO Capital
BMO Capital analyst Matt Borsch is positive on the Aetna (AET) - CVS Health (CVS) merger, saying it accelerates the transformation of healthcare offerings through "the shift to value-based reimbursement, formation of provider 'accountable care organizations', payer-side aggregation of provider assets, and proliferation of lower-cost sites of care" among others. Borsch says that while United Health (UNH) has led this path with Optum, CVS-Aetna partnership may challenge its model. The analyst keeps his Market Perform rating and $200 price target on Aetna, warning that a failed implementation, given the high debt loads and an uncharted path to convert storefronts to healthcare centers, might be "historic".
12/05/17
OPCO
12/05/17
NO CHANGE
OPCO
Perform
Oppenheimer expected higher premium for Aetna shareholders
Oppenheimer analyst Michael Wiederhorn believes CVS Health (CVS) acquisition of Aetna (AET) creates a powerful healthcare competitor. However, he thinks the transaction is more beneficial to CVS given the competitive pressures and need to take action, and he would have expected a higher premium for Aetna shareholders. Wiederhorn reiterates a Perform rating on Aetna's shares.

TODAY'S FREE FLY STORIES

01:45
08/16/18
08/16
01:45
08/16/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

AVLR

Avalara

$34.68

-1.375 (-3.81%)

23:51
08/15/18
08/15
23:51
08/15/18
23:51
Upgrade
Avalara rating change at Goldman Sachs »

Avalara upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$70.61

-0.56 (-0.79%)

23:22
08/15/18
08/15
23:22
08/15/18
23:22
Hot Stocks
SK Telecom deploys Xilinx FPGAs for AI acceleration »

Xilinx jointly announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVC

Invacare

$16.50

0.15 (0.92%)

21:30
08/15/18
08/15
21:30
08/15/18
21:30
Downgrade
Invacare rating change at KeyBanc »

Invacare downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

PRO

Pros Holdings

$35.39

-1.91 (-5.12%)

20:39
08/15/18
08/15
20:39
08/15/18
20:39
Syndicate
Pros Holdings 3.8M share Secondary priced at $34.00 »

It appears selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

  • 21

    Aug

  • 06

    Sep

  • 07

    Sep

  • 16

    Aug

IIN

IntriCon

$63.85

-4.9 (-7.13%)

20:34
08/15/18
08/15
20:34
08/15/18
20:34
Syndicate
IntriCon 1.5M share Secondary priced at $55.00 »

Stifel acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 16

    Aug

ADUS

Addus HomeCare

$59.35

-3.1 (-4.96%)

20:33
08/15/18
08/15
20:33
08/15/18
20:33
Syndicate
Addus HomeCare 2.1M share Secondary priced at $59.00 »

Jefferies, RBC Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

LABL

Multi-Color

$63.90

-1 (-1.54%)

20:32
08/15/18
08/15
20:32
08/15/18
20:32
Downgrade
Multi-Color rating change at KeyBanc »

Multi-Color downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$90.24

-0.565 (-0.62%)

, JCP

J.C. Penney

$2.40

-0.24 (-9.09%)

20:25
08/15/18
08/15
20:25
08/15/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

WMT

Walmart

$90.24

-0.565 (-0.62%)

JCP

J.C. Penney

$2.40

-0.24 (-9.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

WUBA

58.com

$58.59

-3.27 (-5.29%)

19:09
08/15/18
08/15
19:09
08/15/18
19:09
Hot Stocks
Breaking Hot Stocks news story on 58.com »

58.com sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 10

    Sep

WUBA

58.com

$58.59

-3.27 (-5.29%)

19:08
08/15/18
08/15
19:08
08/15/18
19:08
Earnings
58.com reports Q2 adjusted earnings per ADS 82c, consensus 68c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 10

    Sep

WAIR

Wesco Aircraft

$13.65

-0.3 (-2.15%)

19:07
08/15/18
08/15
19:07
08/15/18
19:07
Initiation
Wesco Aircraft initiated at UBS »

Wesco Aircraft initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$21.10

-0.9 (-4.09%)

19:07
08/15/18
08/15
19:07
08/15/18
19:07
Initiation
Triumph Group initiated at UBS »

Triumph Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HXL

Hexcel

$68.40

-1.13 (-1.63%)

19:06
08/15/18
08/15
19:06
08/15/18
19:06
Initiation
Hexcel initiated at UBS »

Hexcel initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ERJ

Embraer

$18.64

-0.495 (-2.59%)

19:05
08/15/18
08/15
19:05
08/15/18
19:05
Initiation
Embraer initiated at UBS »

Embraer initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CW

Curtiss-Wright

$130.92

-2.42 (-1.81%)

19:04
08/15/18
08/15
19:04
08/15/18
19:04
Initiation
Curtiss-Wright initiated at UBS »

Curtiss-Wright initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLL

L3 Technologies

$208.08

-1.73 (-0.82%)

19:03
08/15/18
08/15
19:03
08/15/18
19:03
Initiation
L3 Technologies initiated at UBS »

L3 Technologies initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$192.29

-1.33 (-0.69%)

19:03
08/15/18
08/15
19:03
08/15/18
19:03
Initiation
General Dynamics initiated at UBS »

General Dynamics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$0.00

(0.00%)

19:02
08/15/18
08/15
19:02
08/15/18
19:02
Initiation
Bombardier initiated at UBS »

Bombardier initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEI

Heico

$76.50

-1.81 (-2.31%)

19:00
08/15/18
08/15
19:00
08/15/18
19:00
Initiation
Heico initiated at UBS »

Heico initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 13

    Sep

  • 06

    Nov

HRS

Harris

$162.73

-2.15 (-1.30%)

18:59
08/15/18
08/15
18:59
08/15/18
18:59
Initiation
Harris initiated at UBS »

Harris initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$291.52

-2.35 (-0.80%)

18:59
08/15/18
08/15
18:59
08/15/18
18:59
Initiation
Northrop Grumman initiated at UBS »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$142.03

-0.7 (-0.49%)

, WFC

Wells Fargo

$57.99

-0.08 (-0.14%)

18:57
08/15/18
08/15
18:57
08/15/18
18:57
Periodicals
PNC faces subpoenas over low-income housing tax credits, Bloomberg says »

PNC Financial (PNC) has…

PNC

PNC Financial

$142.03

-0.7 (-0.49%)

WFC

Wells Fargo

$57.99

-0.08 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

UTX

United Technologies

$131.75

-0.65 (-0.49%)

18:57
08/15/18
08/15
18:57
08/15/18
18:57
Initiation
United Technologies initiated at UBS »

United Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

B

Barnes Group

$65.59

-0.26 (-0.39%)

18:56
08/15/18
08/15
18:56
08/15/18
18:56
Initiation
Barnes Group initiated at UBS »

Barnes Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.